Atika Capital Management LLC Invests $2.87 Million in Acadia Healthcare Company, Inc. $ACHC

Atika Capital Management LLC bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 122,600 shares of the company’s stock, valued at approximately $2,868,000.

Several other large investors have also recently made changes to their positions in ACHC. EverSource Wealth Advisors LLC grew its position in shares of Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after purchasing an additional 497 shares in the last quarter. Wells Fargo & Company MN lifted its position in Acadia Healthcare by 208.9% during the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after buying an additional 1,510 shares in the last quarter. Bayforest Capital Ltd acquired a new position in Acadia Healthcare during the fourth quarter worth $52,000. GAMMA Investing LLC grew its holdings in Acadia Healthcare by 124.7% in the 4th quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock valued at $69,000 after buying an additional 2,698 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its position in shares of Acadia Healthcare by 4,264.8% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock valued at $76,000 after acquiring an additional 5,203 shares during the last quarter.

Acadia Healthcare Trading Down 2.2%

Shares of NASDAQ:ACHC opened at $34.01 on Friday. Acadia Healthcare Company, Inc. has a 52 week low of $11.43 and a 52 week high of $35.83. The company’s 50 day moving average is $27.46 and its two-hundred day moving average is $23.10. The company has a market cap of $3.13 billion, a PE ratio of -2.78, a P/E/G ratio of 11.60 and a beta of 0.64. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last issued its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The business had revenue of $828.80 million for the quarter, compared to analyst estimates of $823.51 million. During the same quarter last year, the company earned $0.40 EPS. The business’s quarterly revenue was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Equities analysts predict that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Raymond James Financial upgraded shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price target for the company in a report on Monday, May 4th. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research note on Friday, June 12th. UBS Group lifted their target price on Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research report on Thursday, July 9th. Cantor Fitzgerald upped their price target on Acadia Healthcare from $20.00 to $30.00 and gave the company a “neutral” rating in a research note on Friday, May 1st. Finally, Barclays increased their price target on Acadia Healthcare from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Thursday, April 30th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Acadia Healthcare presently has an average rating of “Hold” and an average price target of $28.69.

View Our Latest Analysis on ACHC

About Acadia Healthcare

(Free Report)

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

Featured Articles

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.